US Broker Ratings

ICON plc (ICLR) Stock Analysis: Evaluating Growth Amidst a Promising 5.61% Potential Upside

ICON plc (NASDAQ: ICLR), a key player in the Healthcare sector under the Diagnostics & Research industry, is emerging as an intriguing option for investors seeking opportunities in the clinical..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Is This Healthcare Giant Still a Buy with Current Valuations?

Medpace Holdings, Inc. (MEDP) is a formidable player within the healthcare sector, specifically in the Diagnostics & Research industry. With a robust market capitalization of $13.14 billion, this Cincinnati-based company..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 24% Potential Upside in the Healthcare Information Sector

Investors seeking opportunities in the healthcare information services sector may find Doximity, Inc. (NASDAQ: DOCS) an intriguing prospect. With a market capitalization of $3.74 billion, this San Francisco-based company is..

Masimo Corporation (MASI) Stock Analysis: Navigating the Healthcare Device Market with Steady Revenue Growth

Masimo Corporation (NASDAQ: MASI), a leading player in the healthcare sector, stands at the forefront of medical device innovation. With a market capitalization of $9.42 billion, Masimo is a significant..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Qiagen N.V. (QGEN) Stock Analysis: Unveiling an 18.59% Potential Upside in the Healthcare Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a leader in the diagnostics and research industry, has been making waves in the healthcare sector. With its headquarters in Venlo, Netherlands, the company specializes in..

Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, commands significant attention from investors navigating the complex landscape of medical instruments and supplies. With a market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 22.8% Potential Upside Amid Strong Growth Prospects

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the specialty and generic drug manufacturing industry, has garnered significant attention from investors due to its impressive market performance and substantial growth..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 23.97% Potential Upside with Strong Buy Ratings

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, specializes in addressing unmet medical needs through its diverse range of pharmaceutical products. With a market capitalization of..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 31.76% Potential Upside for Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a compelling player in the healthcare sector with a pronounced focus on specialty and generic drug manufacturing. Headquartered in Chuo, Japan, and..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 7% Upside Potential Amidst Solid Analyst Support

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, has long been a focal point for investors seeking stability and growth in the healthcare plans industry. With..

Haleon plc (HLN): Analyst Ratings Signal 30% Upside Potential for Investors

Haleon plc (NYSE: HLN), a titan in the consumer healthcare sector, is catching investor attention with a promising outlook. With a market capitalization of $39.55 billion, Haleon operates at the..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: A Biotech Leader with 56.90% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the biotechnology sector, leveraging its robust pipeline of RNA interference-based therapeutics to address unmet medical needs. This Massachusetts-based..

Labcorp Holdings Inc. (LH) Stock Report: Analyst Consensus Points to a 21% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector specializing in diagnostics and research, is attracting attention from investors thanks to its robust market position and promising..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Challenges with a Promising Dividend Yield

Fresenius Medical Care AG (NYSE: FMS), a stalwart in the healthcare sector, provides a crucial service in the medical care facilities industry. With a market cap of $12.67 billion, this..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 13.64% Upside Potential in the Diagnostics & Research Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is drawing investor attention with a compelling 13.64% potential upside. Headquartered in Waltham,..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating a 10.95% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a formidable player in the healthcare sector, specifically within the niche of medical devices. With a market capitalization of $50.3 billion, this Irvine,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Plans Landscape with a 4.48% ROE

In the intricate world of healthcare plans, Molina Healthcare Inc (NYSE: MOH) stands as a significant player with a market capitalization of $10.18 billion. Headquartered in Long Beach, California, Molina..

Becton, Dickinson and Company (BDX) Stock Analysis: Is a 25.5% Potential Upside Within Reach?

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is drawing investor attention with its potential upside of 25.5%, based on its average target price of $180.69...

Insmed Incorporated (INSM) Stock Analysis: Exploring a 105.79% Potential Upside in the Biotech Sector

Investors looking for opportunities in the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing candidate. With a market capitalization of $20.76 billion, Insmed operates from its headquarters in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds